Tom Gevers
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- Epidemiology top 10%
- Respiratory viral infections research
- Mycobacterium research and diagnosis
- Virology and Viral Diseases
Papers in
-
- Tuberculosis Research and Epidemiology 6
- SARS-CoV-2 and COVID-19 Research 1
-
- Respiratory viral infections research 6
- Mycobacterium research and diagnosis 1
- Virology and Viral Diseases 1
- Co-authors
- Koen Andries (13 shared papers)Nacer Lounis (7 shared papers)Luc Vranckx (3 shared papers)Anil Koul (2 shared papers)Nele Coeck (1 shared paper)Cristina Villellas (1 shared paper)Bouke Catherine de Jong (1 shared paper)Kim Thys (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (5 papers)Antiviral Research (2 papers)Journal of Medicinal Chemistry (2 papers)Journal of Clinical Microbiology (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesBelgium
In The Last Decade
Tom Gevers
13 papers receiving 906 citations
Tom Gevers's Hit Papers
Peers
Comparison fields: 5 of 45
- Infectious Diseases 561
- Epidemiology 296
- Molecular Medicine 19
- Organic Chemistry 92
- Virology 10
Countries citing papers authored by Tom Gevers
This map shows the geographic impact of Tom Gevers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Gevers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Gevers more than expected).
Fields of papers citing papers by Tom Gevers
This network shows the impact of papers produced by Tom Gevers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Gevers. The network helps show where Tom Gevers may publish in the future.
Co-authors
The 25 scholars most cited alongside Tom Gevers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline Hit paper breakdown → | 2014 | 343 |
| 2 | 2011 | 99 | |
| 3 | 2003 | 98 | |
| 4 | 2008 | 82 | |
| 5 | 2009 | 76 | |
| 6 | 2008 | 54 | |
| 7 | 2010 | 48 | |
| 8 | 2009 | 46 | |
| 9 | 2007 | 41 | |
| 10 | 2008 | 36 | |
| 11 | 2010 | 21 | |
| 12 | 2016 | 21 | |
| 13 | R170591, a New Antiviral with picoMolar Activity against Respiratory Syncytial Virus. | 2001 | 1 |
About Tom Gevers
Tom Gevers is a scholar working on Infectious Diseases, Epidemiology, Computational Theory and Mathematics, Organic Chemistry and Nuclear Energy and Engineering, having authored 13 papers that have together received 966 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (6 papers), Respiratory viral infections research (6 papers), Computational Drug Discovery Methods (2 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), Mycobacterium research and diagnosis (1 paper) and Virology and Viral Diseases (1 paper). The work is most often cited by research in Infectious Diseases (561 citations), Epidemiology (296 citations), Molecular Medicine (19 citations), Organic Chemistry (92 citations) and Virology (10 citations). Tom Gevers has collaborated with scholars based in United States and Belgium. Frequent co-authors include Koen Andries, Nacer Lounis, Luc Vranckx, Anil Koul, Nele Coeck, Cristina Villellas, Bouke Catherine de Jong, Kim Thys, Rudy Willebrords and Frans E. Janssens. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Antiviral Research, Journal of Medicinal Chemistry, Journal of Clinical Microbiology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.